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Endometriosis is diagnosed when tissue
which resembles the endometrial lining exists
outside the endometrial cavity Although first
described as a pathological entity in the late
1800s, the term "endometriosis" was not in
troduced until the early 1920s by Sampson '
The great volume of literature which has accu
mulated on this topic is, by and large, a product
of the 20th century.
Many theories exist as to the histogenesis
of endometriosis. All may be assigned to one of
three basic groups in which 1) endometrial tis
sue is transplanted ectopically as a result of re
gurgitation, metastasis, or oviduct extension, 2)
endometrial tissue develops ectopically in situ
from local tissues, or 3) a combination of trans
plantation and development in situ. Of the three
groups, only the first has been documented; the
other two are speculative.?
Grossly, endometriosis often presents as
purplish, dusky red, or brownish spots or ele
vated nodules surrounded by varying degrees
of fibrosis and scarring Typically it involves the
peritoneal surface of the ovary or ovaries, cul
de-sac, or bladder. Less frequently the bowel,
appendix, bladder, ureters, cervix, vagina, and
vulva are involved. Rarely, it is reported in the
umbilicus, pleura, lungs, and extremities. Trans
plantation into surgical incisions ot the abdomi
nal wall and perineum has been documented.
Microscopic evidence of endometriosis is
not always clear-cut. One would like to see en
dometrial-like epithelium, glands or gland-like
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structures. and stroma accompanied by evi
dence of hemorrhage. Not infrequently a picture
"consistent with endometriosis" will present it
self revealing hemosiderin, fibroblasts, and pig
ment-laden macrophages However, one can
not be secure in the pathological diagnosis if it
is based solely on such evidence.
Malignant degeneration occurring within
areas of endometriosis is uncommon-less
than 1%. When it does occur, it is seen much
more frequently in the glandular component as
an adenocarcinoma than in the the stromal
component; rarely is the malignancy of a mixed
type Endometroid carcinoma of the ovary does
not appear to be directly related in its histogen
esis to endometriosis.
Clinically, endometriosis is a disease of
the reproductive years. Although it is being seen
more frequently in teenagers, it has never been
reported to occur before the menarche. The dis
ease may pose a problem for the peri
menopausal woman.
The frequency with which endometriosis is
reported to occur in a given population is highly
variable. Perhaps as many as 20% to 25% of
women 24-45 years old have some evidence of
endometriosis recognizable at the time of lap
aroscopy. It is being detected with increasing
frequency in blacks, historically a group thought
to have a very low incidence of the disease.
The patient with endometriosis usually
complains of secondary dysmenorrhea or pelvic
pain, menstrual abnormalities, and frequently ol
infertility
The pain is highly variable and its severity
often cannot be related to the extent of the dis
ease. Pain usually begins some years after

:nenarche and may be premenstrual or men
strual in occurrence. Extensive endometriosis
may be associated with chronic pain throughout
the menstrual cycle. Sometimes the disease
causes pelvic pressure or a sense of heaviness
and fullness which the patient does not interpret
as pain. Low backache and deep dyspareunia
are usually the result of uterosacral involvement.
Rectal and bladder tenesmus occurs and cyclic
sciatica (Head sign) has been reported.
Abormalities of menstruation consisting of
hypermenorrhea and an irregular menstrual in
terval imply ovarian involvement. Ten percent of
patients with significant endometriosis have epi
sodes of anovulation. As the disease is com
monly associated with an increased incidence
of endometrial polyps, leiomyomata, and ade
nomyosis, these conditions must also be sus
pect as causes of abnormal menstruation.
Infertility may be the result of a number of
factors: ovarian dysfunction, kinking of the ovi
ducts, scarring of the fimbria, uterotubal spasm,
and a decrease in coital exposure due to dyspa
reunia and chronic pelvic discomfort. This prob
lem becomes more perplexing, however, when
one is reminded that most patients with endo
metriosis ovulate, few have blocked tubal lu
mens, and many have previously borne chil
dren.
The patient with complaints suggestive of
endometriosis may or may not have the classic
physical findings of pelvic tenderness, cul-de
sac nodularity, organ fixation, or abnormal ad
nexal masses. Many, with minimal endometrio
sis, appear to offer the most complaints,
whereas others, with extensive involvement,
may appear relatively asymptomatic. There is
yet another group in which endometriosis is only
an incidental finding at the time of laparoscopy
or laparotomy.
Although the pelvic findings may confirm
the suspicion of endometriosis, the diagnosis
cannot be made unless the disease process is
visualized or biopsied. Laparoscopy has proved
invaluable in the diagnosis and ma�agement of
patients suspected of having endometriosis. In
dications for laparoscopy are given in Table 1.
When endometriosis is encountered, diagrams
of the extent of involvement should be entered
in the patient's medical record. The Baylor
classification of pelvic endometriosis is helpful
in documenting findings and serving as a guide
to medical and/or surgical therapy (Table 2). 3

TABLE 1
Indications for Laparoscopy

Severe unexplained pelvic pain
Progressively severe dysmenorrhea
Dyspareunia, especially with deep penetration
Metrorrhagia uncontrolled by dilatation and curettage and/
or hormones
Pelvic findings suggestive of endometriosis
Unexplained infertility

Medical management of endometriosis is
aimed at the relief of pelvic discomfort and the
preservation of the patient's childbearing poten
tial. Initially, analgesics and heat may provide
relief. The patient should be advised to avoid
the continued use of narcotics and alcoholic
beverages. It is best not to undertake the medi
cal suppression of endometriosis using hor
monal therapy unless the disease has been
documented visually or by biopsy, and the ex
tent of involvement determined. Hormonal ther
apy is associated with many undesirable side
effects and is expensive. Patients thought to
have the disease but who in fact do not have it
should be spared prolonged courses of hor
monal therapy.
Current hormonal regimens employ the
TABLE 2
Classification and Treatment

MILD:

MODERATE:

SEVERE:

Fresh implants. minimal scarring, no
adhesions. minimal or no ovarian involve·
ment
Rx: Medical suppression
Gestogens (pseudopregnancy)
Danazol (pseudomenopause)
Supportive therapy
Analgesics. heat
No therapy
Implants with scarring and retraction,
adhesions, endometrioma <2 cm,
minimal peritubular and periovarian adhe
sions
Rx: Laparoscopic minisurgery
Conservative surgery
Medical suppression
Endometrioma >2 cm, tube(s) and
ovary or ovaries bound down by adhe
sions. cul-de-sac obliteration. bowel or uri
nary tract involvement
Rx: Conservative surgery
Hysterectomy with salpingo-oophorec
tomy
Medical suppression. postoperative. if
indicated
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gestogens to achieve pseudopregnancy or dan
azol to achieve pseudomenopause Hormones
appear to give the best results in the treatment
of mild degrees of endometriotic involvement.
They are capable of relieving pain and of reduc
ing the extent of the disease to some degree;
however. they are not likely to eliminate all foci
of disease and thereby effect a cure.
The gestogens, combinations of estrogen
and progesterone, interrupt the negative feed
back within the hypothalamic-pituitary-ovarian
axis at the pituitary level. Follicle stimulating hor
mone (FSH) and luteinizing hormone (LH) secre
tions are suppressed. ovarian follicular develop
ment and ovulation are inhibited. and the
secretion of ovarian estrogen and progesterone
is reduced. The inherent estrogenic and pro
gestational properties of the gestogens initially
stimulate endometrial growth and induce decid
ual change within the endometrjal tissue. Sub
sequently, amenorrhea and gradual atrophy of
the uterine and ectopic endometrial tissue re
sults in symptomatic relief. Pseudopregnancy
regimens have been reported to provide symp
tomatic relief in up to 94% of patients and a
corrected pregnancy rate after treatment as
high as 50%.'' The return of symptoms and the
recurrence of endometriosis after therapy ap
pear to increase progressively with the length of
follow-up unless menopause ensues. The side
effects of gestogen therapy include nausea,
mastodynia, vaginal discharge, fluid retention,
breakthrough bleeding, and on occasion,
thromboembolism. Pseudopregnancy regimens
should be avoided in patients with a history of
thromboembolic disease and breast or endome
trial carcinoma.
Danazol, a weak synthetic testosterone,
has antigonadotrophic properties similar to the
gestogens. It is capable of inducing a pseudo
menopausal state with its associated amenor
rhea and endometrial atrophy but is unasso
ciated with many of the undesirable side effects
of gestogen therapy. Danazol suppresses FSH
and LH secretion and therefore inhibits follicular
development, ovulation, and corpus luteum for
mation. Ovarian estrogen and progesterone se
cretion is reduced to a minimum, causing endo
metrial atrophy and amenorrhea. This inactivity
and atrophy of ectopic endometrial tissue al
lows reabsorption and healing Side effects of
danazol therapy include the vasomotor symp
toms of menopause, weight gain, edema, vagi'.34
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nal spotting, and acne. Fortunately, significanl
androgenic effects are rare as the usual anti
gonadotrophic dose required for the treatmenl
of endometriosis is approximately one third thal
capable of causing masculinization in the
woman. Symptomatic improvement with thE
danazol-pseudomenopausal regimen is re
ported in up to 92% of patients Clinical im
provement is noted in approximately 60% and
a corrected pregnancy rate of 50% is said to
exist. Unfortunately, the recurrence of symp
toms is relatively high after discontinuance ol
therapy. As with the pseudopregnancy regimen,
conception after therapy prolongs the asympto
matic interval.
Moderate involvement with endometriosis
is best treated with laparoscopic minisurgery fo,
the lysis of adhesions, freeing of the ovaries,
and cauterization of implants; a more extensive
laparotomy may be required. Conservative sur
gery, in cases of moderate and severe in
volvement with endometriosis, is undertaken in
an effort to correct reflux menstruation, relieve
pelvic pain. and improve fertility. It consists pri
marily of lysis of adhesions, the excision or de
struction of all discernable endometriotic im
plants and cysts, and is often accompanied by
uterine suspension and presacral neurectomy in
an effort to prevent subsequent retrofixation ol
the uterus and provide relief of pelvic pain Con
servative surgical approaches have been shown
markedly to improve symptoms and child
bearing potential. The addition of a pseudo
pregnancy regimen to surgery, although recom
mended by some, has in most cases not
significantly added to the success of the opera,
lion as measured by subsequent pregnancy o
reducing the need for future surgery Approxi
mately one quarter of patients undergoing con
servative surgical therapy for endometriosis wil
require future operative procedures because o
endometriotic involvement. 5
In severe cases of endometriotic in
volvement, "radical" surgery, such as total ab
dominal hysterectomy and bilateral salpingo·
oophorectomy, may offer the only hope of c
cure. II this is not an acceptable alternative fo1
the particular patient, the physician should real
istically think in terms of palliation rather than
cure. The growth of ectopic endometrial tissu�
cannot be permanently eradicated as long as
functioning ovarian tissue remains within th�
body Castration causes the involution an�

death of active foci of endometriosis; however,
the patient may still be left with fibrotic adhe
sions and other residua which continue as a
source of chronic pain. In selected cases, it
may be advisable to follow a surgical approach
to the treatment of endometriosis with a
pseudopregnancy or pseudomenopausal regi
men for the continued suppression of residual
disease.
Hormonal therapy for the surgically-in
duced menopause may be required. If this can
be anticipated, it is best to be sure that all foci
of disease are removed at the time of surgery
and not to depend upon castration alone to in
activate residual disease. 11 au endometriosis
has been removed, the patient may be started
on conjugated equine estrogen. If it is thought
that some endometriosis remains, it is best to
delay hormonal therapy for six months or treat
the patient for that period of time with me
droxyprogesterone acetate; subsequently con-

jugated equine estrogen therapy may be insti
tuted on a cyclic basis.
Table 2 is adapted from Obstetrics and Gynecology
(42: 19-25. 1973).
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